Following the recently released results from CLINUVEL’s CUV156 and CUV151 studies, CLINUVEL’s expert genomic scientist, Dr Jessica Nucci, explains how DNA damage can increase the risk of cancer, and shares how melanocortins can help patients with xeroderma pigmentosum to mitigate this risk, as well as the next steps in the Company’s DNA Repair Program.
Stay up to date on Our DNA Repair Program.
Read the technical note accompanying the CUV156 announcement.